Selective sensitivity to wasabi-derived 6-(methylsulfinyl)hexyl isothiocyanate of human breast cancer and melanoma cell lines studied in vitro

Kinae, 2000, Functional properties of wasabi and horseradish, Biofactors, 13, 265, 10.1002/biof.5520130140 Morimitsu, 2000, Antiplatelet and anticancer isothiocyanates in Japanese domestic horseradish, Wasabi, Mech Ageing Dev, 116, 125, 10.1016/S0047-6374(00)00114-7 Fuke, 1994, Growth suppression of MKN-28 human stomach cancer cells by wasabi (Eutrema wasabi Maxim.), Nippon Shokuhin Kogyo Gakkaishi, 41, 709, 10.3136/nskkk1962.41.709 Ono, 1996, Purification and structural analysis of substances in wasabi (Eutrema wasabi Maxim.) that suppress the growth of MKN-28 human stomach cancer cells, J Jpn Food Sci Technol, 43, 1092, 10.3136/nskkk.43.1092 Etoh, 1990, 6-Methylsulfinylhexyl isothiocyanates in wasabi, Wasabia japonica Matsum, Agric Biol Chem, 54, 1587, 10.1271/bbb1961.54.1587 Fuke, 1997, Anti-carcinogenic activity of 6-methylsulfinylhexyl isothiocyanates (6-MITC), and an active antiproliferative principal of wasabi (Eutrema wasabi Maxim.), Cytotechnology, 25, 197, 10.1023/A:1007918508115 Yano, 2000, The effect of 6-methylthiohexyl isothiocyanate isolated from Wasabia japonica (wasabi) on 4-(methylnitrosamino)-1-(3-pyridyl)-1-buatnone-induced lung tumorigenesis in mice, Cancer Lett, 155, 115, 10.1016/S0304-3835(00)00364-5 Fuke, 2000, Suppression effect on tumor metastasis by 6-(methylsulfinyl)hexyl isothiocyanate from wasabi, Nippon Shokuhin Kogyo Gakkaishi, 47, 760, 10.3136/nskkk.47.760 Fuke, 2003, 6-(Methylsulfinyl)hexyl isothiocyanate isolated from wasabi (Wasabia japonica Matsum) suppresses the tumor metastasis in an experimental mouse system, Food Sci Technol Res, 9, 148, 10.3136/fstr.9.148 Paull, 1989, Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm, J Natl Cancer Inst, 81, 1088, 10.1093/jnci/81.14.1088 Yamori, 1997, A human cell line panel for screening anti-cancer drugs, Gan To Kagaku Ryoho, 24, 129 Yamori, 1999, Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel, Cancer Res, 59, 4042 Yamori, 2000, Results of the evaluation of anti-cancer agents by using human cancer cell panels: details of interpretation, Gan To Kagaku Ryoho, 27, 159 Naasani, 2002, Screening with COMPARE analysis for telomerase inhibitors, Meth Mol Biol, 191, 197 Monks, 1991, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines, J Natl Cancer Inst, 83, 757, 10.1093/jnci/83.11.757 Skehan, 1990, New colorimetric cytotoxicity assay for anticancer-drug screening, J Natl Cancer Inst, 82, 1107, 10.1093/jnci/82.13.1107 Yamori, 1997, Anti-tumor efficacy of paclitaxel against human lung cancer xenografts, Jpn J Cancer Res, 88, 1205, 10.1111/j.1349-7006.1997.tb00350.x Watanabe, 2003, Identification of 6-methylsulfinylhexyl isothiocyanate as an apoptosis-inducing component in wasabi, Phytochemistry, 62, 733, 10.1016/S0031-9422(02)00613-1 Hou, 2000, Transcriptional regulation of nicotinamide adenin dinucleotide phosphate: uinone oxidoreductase in murine hepatoma cells by 6-(methylsulfinyl)hexyl isothiocyanate, an active principle of wasabi (Eutrema wasabi Maxim.), Cancer Lett, 161, 195, 10.1016/S0304-3835(00)00611-X Morimitsu, 2002, A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway, J Biol Chem, 277, 3456, 10.1074/jbc.M110244200 Morgan, 1979, Cytotoxic drugs and the human adrenal cortex: a cell culture study, Cancer, 43, 969, 10.1002/1097-0142(197903)43:3<969::AID-CNCR2820430328>3.0.CO;2-5 Berne, 1988, Inhibition of thymidylate synthase after ministration of doxifluridine in a transplantable colon carcinoma in the rat, Cancer Invest, 6, 377, 10.3109/07357908809080065 Tominaga, 2003, Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery, J Clin Oncol, 21, 991, 10.1200/JCO.2003.06.014 Yoshimoto, 2003, The potential for oral combination chemotherapy of 5′-deoxy-5-fluorouridine, a 5-FU prodrug, and cyclophosphamide for metastatic breast cancer, Br J Cancer, 89, 1627, 10.1038/sj.bjc.6601350